These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A rare cause of myocardial infarction: acute inferoposterior myocardial infarction after successful intravenous thrombolytic treatment of mechanical mitral prosthetic valve thrombosis. Altinbas A; Kucuktepe Z; Ozaydin M; Aslan SM; Demir M; Altinbas E Int J Cardiovasc Imaging; 2005 Oct; 21(5):509-12. PubMed ID: 16175440 [TBL] [Abstract][Full Text] [Related]
4. Thrombin generation after fast or prolonged regimens of tissue-type plasminogen activator. Andreotti F; Kluft C; Hackett DR; Davies GJ; Maseri A Lancet; 1993 Oct; 342(8876):937-8. PubMed ID: 8105201 [No Abstract] [Full Text] [Related]
5. Fatal intracerebral hemorrhage following thrombolytic therapy of embolic myocardial infarction in unsuspected infective endocarditis. Di Salvo TG; Tatter SB; O'Gara PT; Nielsen GP; DeSanctis RW Clin Cardiol; 1994 Jun; 17(6):340-4. PubMed ID: 8070153 [TBL] [Abstract][Full Text] [Related]
6. Anaphylactoid reaction during an infusion of recombinant tissue-type plasminogen activator for acute myocardial infarction. Massel D; Gill JB; Cairns JA Can J Cardiol; 1991 Sep; 7(7):298-302. PubMed ID: 1933636 [TBL] [Abstract][Full Text] [Related]
7. Spontaneous arterial embolization after thrombolytic therapy for acute myocardial infarction: the role of transesophageal echocardiography. Karalis DG; Kaulback KW; Ross JJ; Uricchio FJ; Chandrasekaran K Cathet Cardiovasc Diagn; 1994 Mar; 31(3):199-201. PubMed ID: 8025936 [TBL] [Abstract][Full Text] [Related]
8. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog. Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384 [TBL] [Abstract][Full Text] [Related]
9. [A trial of the use of a new thrombolytic preparation--recombinant tissue-type plasminogen activator--in myocardial infarct patients]. Plotnikov AN; Staroverov II; Tagieva IA; Dorogun BN; Pomerantsev EV; Dobrovol'skiĭ AB; Ruda MIa Kardiologiia; 1993; 33(3):32-6. PubMed ID: 8377337 [TBL] [Abstract][Full Text] [Related]
10. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis. Przyklenk K; Kloner RA Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780 [TBL] [Abstract][Full Text] [Related]
11. Increase in platelet support of thrombin generation after thrombolytic therapy. Chang P; Aronson DL; Scott J; Kessler CM Am J Cardiol; 1992 Aug; 70(3):406-8. PubMed ID: 1632418 [No Abstract] [Full Text] [Related]
16. Systemic thrombolysis for early intracoronary stent thrombosis. Fruhwald FM; Luha O; Eber B; Schumacher M; Zweiker R; Klein W Lancet; 1995 Jul; 346(8967):119-20. PubMed ID: 7603192 [No Abstract] [Full Text] [Related]
17. [Myocardial infarction, late fibrinolysis and resolving cerebral embolism]. Lescure M; Lagorce P; Caussanel JP; Malbec M Ann Cardiol Angeiol (Paris); 1993 Jan; 42(1):25-7. PubMed ID: 8480981 [TBL] [Abstract][Full Text] [Related]
18. [Bilateral renal embolism during thrombolytic therapy with tissue-type plasminogen activator in a patient with thrombosis of the left ventricle]. Abassade P; Iung B; Baudouy PY; Vuong PN; Valleteau de Moulliac M Arch Mal Coeur Vaiss; 1991 Apr; 84(4):583-5. PubMed ID: 1905916 [TBL] [Abstract][Full Text] [Related]
19. Haemarthrosis following thrombolytic therapy for acute myocardial infarction. Finlayson J; Dunsmuir RA Injury; 1997 Mar; 28(2):146-7. PubMed ID: 9205584 [No Abstract] [Full Text] [Related]